Javascript must be enabled to continue!
Platelet Count Pitfalls Between Routine and Advanced Techniques
View through CrossRef
Background: Precise quantification of platelet counts is a fundamental aspect of clinical hematology, pivotal in diagnosing and managing conditions such as thrombocytopenia and thrombocytosis. However, inconsistencies in platelet measurements across various automated hematology analyzers present significant challenges, potentially compromising the reliability of results. This variability is especially critical when platelet counts inform urgent clinical interventions, including the administration of platelet transfusions. Aim: The present study evaluated the accuracy of Sysmex XN-350 and Mindray in comparison to flow cytometry, the gold standard for platelet counting. Methods: 120 blood samples were categorized into thrombocytopenic, thrombocytosis, and normal groups. Platelet counts were measured using Sysmex XN-350, Mindray BC-720, and flow cytometry. Statistical analyses, including correlation coefficients, Bland-Altman plots, and repeated measures ANOVA, were employed to assess agreement and differences among the methods. Results: The study revealed significant discrepancies in platelet counts among the devices. Sysmex XN-350 consistently overestimated platelet counts compared to flow cytometry, particularly at higher counts, with a mean difference of 176.76 ± 358.51. Mindray BC-720 demonstrated greater agreement with flow cytometry, with a mean difference of 60.062 ± 119.67 and a stronger correlation (r = 0.972). Bland-Altman analysis showed that Sysmex exhibited substantial overestimation at higher platelet counts, while Mindray maintained consistency within clinically relevant ranges. Conclusions: Mindray BC-720 outperformed Sysmex XN-350 in terms of agreement with flow cytometry, especially in the thrombocytopenic and normal ranges. These findings highlight the importance of validating automated hematology analyzers against advanced techniques like flow cytometry to ensure precision in platelet enumeration.
Iraqi Association for Medical Research and Studies
Title: Platelet Count Pitfalls Between Routine and Advanced Techniques
Description:
Background: Precise quantification of platelet counts is a fundamental aspect of clinical hematology, pivotal in diagnosing and managing conditions such as thrombocytopenia and thrombocytosis.
However, inconsistencies in platelet measurements across various automated hematology analyzers present significant challenges, potentially compromising the reliability of results.
This variability is especially critical when platelet counts inform urgent clinical interventions, including the administration of platelet transfusions.
Aim: The present study evaluated the accuracy of Sysmex XN-350 and Mindray in comparison to flow cytometry, the gold standard for platelet counting.
Methods: 120 blood samples were categorized into thrombocytopenic, thrombocytosis, and normal groups.
Platelet counts were measured using Sysmex XN-350, Mindray BC-720, and flow cytometry.
Statistical analyses, including correlation coefficients, Bland-Altman plots, and repeated measures ANOVA, were employed to assess agreement and differences among the methods.
Results: The study revealed significant discrepancies in platelet counts among the devices.
Sysmex XN-350 consistently overestimated platelet counts compared to flow cytometry, particularly at higher counts, with a mean difference of 176.
76 ± 358.
51.
Mindray BC-720 demonstrated greater agreement with flow cytometry, with a mean difference of 60.
062 ± 119.
67 and a stronger correlation (r = 0.
972).
Bland-Altman analysis showed that Sysmex exhibited substantial overestimation at higher platelet counts, while Mindray maintained consistency within clinically relevant ranges.
Conclusions: Mindray BC-720 outperformed Sysmex XN-350 in terms of agreement with flow cytometry, especially in the thrombocytopenic and normal ranges.
These findings highlight the importance of validating automated hematology analyzers against advanced techniques like flow cytometry to ensure precision in platelet enumeration.
Related Results
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposition following an enviro...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Abstract
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposi...
Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)
Real-world clinical trial of hetrombopag (TPO-RA) in the treatment of primary immune thrombocytopenia (ITP)
Abstract
Background: Primary immune Thrombocytopenia (ITP) is an acquired autoimmune hemorrhagic disorder characterized ...
Platelet count patterns and patient outcomes in sepsis at a tertiary care center
Platelet count patterns and patient outcomes in sepsis at a tertiary care center
Abstract
Acute physiology and chronic health evaluation II (APACHE-II) scoring system is used to classify disease severity of patients in the intensive care unit. Howev...
Routine Prophylactic Platelet Transfusions Are Not Necessary in Patients with Acute Myeloid Leukemia - A Therapeutic Transfusion Strategy Is Safe and Cost Effective.
Routine Prophylactic Platelet Transfusions Are Not Necessary in Patients with Acute Myeloid Leukemia - A Therapeutic Transfusion Strategy Is Safe and Cost Effective.
Abstract
During the last three years 60 patients with newly diagnosed acute myeloid leukemia (except FAB M3) were included in a therapeutic platelet transfusion prot...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Plasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect of aspi...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
AbstractPlasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect...
Reticulocyte Count and Platelet Count as Predictors of Morphological Remission/Hemopoitic Recovery in Acute Lymphoblastic Leukemia (ALL) after Induction Chemotherapy
Reticulocyte Count and Platelet Count as Predictors of Morphological Remission/Hemopoitic Recovery in Acute Lymphoblastic Leukemia (ALL) after Induction Chemotherapy
Objectives: To determine the predictive values of reticulocyte and platelet count for remission in cases of acute lymphoblastic leukemia after induction therapy.
Materials and Me...

